Effects of Plavix (clopidogrel) on platelet inhibition in dogs with Protein Losing Nephropathy (PLN)


To evaluate the effect of plavix dosing in respect to how much time is needed to achieve maximum platelet inhibition which may decrease risk of thrombeombolic disease.

Inclusion Criteria

Diagnosis of protein losing nephropathy, cases with high indices of suspicion without definitive diagnosis will also be considered.

Exclusion Criteria

Dogs will be excluded if they have received steroids or any anticoagulant medications.

Client Benefits

May be able to use a lower dose of plavix, therefore, more cost-effective.

Contact Information

Diane Welsh, Clinical Trials Technician clinicaltrials@tufts.edu